WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing ...

AlphaQuest LLC increased its stake in shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN – Free Report) by 119.0% during the fourth quarter, HoldingsChannel.com reports. The firm owned 2,795 shares of ...

This theory "justifies" Pikachu's presence in the Viridian Forest in the early Pokémon games by a terrible real-world ...

Viridian Therapeutics (NASDAQ:VRDN) shares shot up 25% in early trading Monday after the company reported positive topline results from a Phase 3 study of its drug veligrotug in the treatment of ...

Investment analysts at B. Riley issued their Q1 2025 earnings per share estimates for Viridian Therapeutics in a research report issued to clients and investors on Monday, March 3rd. B. Riley analyst ...

Viridian designed VRDN-003 to be an infrequent, at-home, and self-administered subcutaneous injection using a low-volume autoinjector. REVEAL-1 and REVEAL-2 Progressing as Planned: Patient ...

Thyroid eye disease (TED) therapy Tepezza – the biggest asset in Amgen's $26 billion takeover of Horizon last year – could soon face competition from a drug in the same class from Viridian ...

Arguably the worst way to play a game is via a Twitch chat comments, which was popularized by Twitch Plays Pokemon. But now ...

Viridian Advisory’s latest survey revealed that the looming Federal Budget is stirring public concern, with cost of living, ...

--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for serious and rare ...